华统股份(002840) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 reached ¥2,561,261,774.59, representing a 57.17% increase compared to the same period last year[6] - Net profit attributable to shareholders was ¥104,445,123.69, a significant increase of 200.95% year-on-year[6] - The basic earnings per share rose to ¥0.19, reflecting an increase of 181.18% compared to the previous year[6] - The net profit attributable to shareholders reached ¥45,365,707.19, a significant increase of 909.18% driven by improved profitability in the pig farming segment[16] - Basic and diluted earnings per share increased by 600.00% to ¥0.07, reflecting enhanced profitability[16] - The total operating profit for the current period is approximately 59.34 million, compared to 33.51 million in the previous period, reflecting a significant increase[46] - The net profit for the current period is approximately 61.07 million, up from 7.62 million in the previous period, indicating a substantial growth[46] - The net profit attributable to shareholders of the parent company is approximately 45.37 million, compared to 4.50 million in the previous period, showing a strong improvement[48] - The total comprehensive income for the current period is approximately 61.07 million, compared to 7.62 million in the previous period, highlighting a positive trend[48] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥9,096,730,320.51, marking a 27.47% increase from the end of the previous year[6] - Current assets totaled ¥2,749,089,493.41, compared to ¥1,274,901,332.00 in the previous year, reflecting a significant increase of approximately 115.5%[31] - Total liabilities increased to ¥5,587,833,650.90 from ¥5,021,642,744.05, which is an increase of about 11.2%[38] - Long-term borrowings stood at ¥1,767,959,422.55, slightly up from ¥1,717,434,550.28, indicating a growth of about 2.8%[38] - The company's total equity increased to ¥3,508,896,669.61 from ¥2,114,626,268.21, reflecting a growth of approximately 65.7%[38] - The company's equity attributable to shareholders increased by 72.49% to ¥2,659,118,984.60 compared to the end of the previous year[6] Cash Flow - Cash flow from operating activities for the year-to-date was ¥164,450,567.20, up 43.48% year-on-year[6] - The net cash flow from operating activities was ¥164,450,567.20, up 43.48% compared to ¥114,616,506.45 in the previous period, mainly due to rising pig prices[16] - Cash flow from operating activities for the current period is approximately 164.45 million, compared to 114.62 million in the previous period, reflecting improved cash generation[52] - Cash flow from investing activities shows a net outflow of approximately 872.71 million, compared to a net outflow of 1.63 billion in the previous period, indicating reduced investment losses[55] - Cash flow from financing activities for the current period is approximately 1.50 billion, compared to 1.36 billion in the previous period, demonstrating strong financing capabilities[55] - The ending cash and cash equivalents balance is approximately 1.21 billion, up from 416.66 million in the previous period, indicating a significant increase in liquidity[55] - The company received approximately 1.19 billion in cash from investment, a notable increase from 174.10 million in the previous period, reflecting strong investor confidence[55] Expenses - Management expenses for the current period amounted to ¥129,658,280.53, an increase of 34.36% compared to the previous period due to increased management personnel and depreciation costs[16] - R&D expenses rose to ¥23,082,781.91, reflecting a 55.50% increase as the company expanded its R&D projects[16] - Financial expenses surged by 117.87% to ¥143,930,189.55, primarily due to the cessation of capitalizing costs related to pig farm production[16] - Research and development expenses for the quarter were ¥23,082,781.91, compared to ¥14,844,013.23 in the same period last year, representing a year-over-year increase of approximately 55.5%[43] Other Financial Metrics - The weighted average return on equity was 6.81%, an increase of 12.68% compared to the previous year[6] - Other income increased by 88.00% to ¥60,234,005.27, attributed to higher government subsidies received[16] - The company received government subsidies amounting to ¥17,842,595.26 during the reporting period[7] - The company reported an asset impairment loss of ¥75,664,993.48, a 397.68% increase due to rising pig prices affecting biological asset valuations[16] - Investment income turned negative at -¥2,398,323.16, a decline of 105.11% compared to the previous year, primarily due to the sale of subsidiary equity last year[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,428, with no preferred shareholders[17] - Total operating revenue for the third quarter of 2022 reached ¥6,419,283,549.56, an increase from ¥6,245,428,625.52 in the same period last year, representing a growth of approximately 2.8%[39] - Total assets as of September 30, 2022, amounted to ¥9,096,730,320.51, up from ¥7,136,269,012.26, indicating a year-over-year increase of about 27.5%[38]